Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

1.

Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.

Bazzini S, Udine C, Riccardi G.

Appl Microbiol Biotechnol. 2011 Dec;92(5):887-95. doi: 10.1007/s00253-011-3616-5. Epub 2011 Oct 14. Review.

PMID:
21997606
[PubMed - indexed for MEDLINE]
2.

Deciphering the role of RND efflux transporters in Burkholderia cenocepacia.

Bazzini S, Udine C, Sass A, Pasca MR, Longo F, Emiliani G, Fondi M, Perrin E, Decorosi F, Viti C, Giovannetti L, Leoni L, Fani R, Riccardi G, Mahenthiralingam E, Buroni S.

PLoS One. 2011 Apr 19;6(4):e18902. doi: 10.1371/journal.pone.0018902.

PMID:
21526150
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance.

Buroni S, Pasca MR, Flannagan RS, Bazzini S, Milano A, Bertani I, Venturi V, Valvano MA, Riccardi G.

BMC Microbiol. 2009 Sep 17;9:200. doi: 10.1186/1471-2180-9-200.

PMID:
19761586
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.

Guglierame P, Pasca MR, De Rossi E, Buroni S, Arrigo P, Manina G, Riccardi G.

BMC Microbiol. 2006 Jul 20;6:66.

PMID:
16857052
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis.

Sass A, Marchbank A, Tullis E, Lipuma JJ, Mahenthiralingam E.

BMC Genomics. 2011 Jul 22;12:373. doi: 10.1186/1471-2164-12-373.

PMID:
21781329
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.

Drevinek P, Mahenthiralingam E.

Clin Microbiol Infect. 2010 Jul;16(7):821-30. doi: 10.1111/j.1469-0691.2010.03237.x. Review.

PMID:
20880411
[PubMed - indexed for MEDLINE]
7.

Differential Roles of RND Efflux Pumps in Antimicrobial Drug Resistance of Sessile and Planktonic Burkholderia cenocepacia Cells.

Buroni S, Matthijs N, Spadaro F, Van Acker H, Scoffone VC, Pasca MR, Riccardi G, Coenye T.

Antimicrob Agents Chemother. 2014 Dec;58(12):7424-9. doi: 10.1128/AAC.03800-14. Epub 2014 Sep 29.

PMID:
25267676
[PubMed - in process]
8.

Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia.

Scoffone VC, Spadaro F, Udine C, Makarov V, Fondi M, Fani R, De Rossi E, Riccardi G, Buroni S.

Antimicrob Agents Chemother. 2014;58(4):2415-7. doi: 10.1128/AAC.02438-13. Epub 2014 Jan 6.

PMID:
24395233
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The suhB gene of Burkholderia cenocepacia is required for protein secretion, biofilm formation, motility and polymyxin B resistance.

Rosales-Reyes R, Saldías MS, Aubert DF, El-Halfawy OM, Valvano MA.

Microbiology. 2012 Sep;158(Pt 9):2315-24. doi: 10.1099/mic.0.060988-0. Epub 2012 Jul 5.

PMID:
22767545
[PubMed - indexed for MEDLINE]
Free Article
10.

Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction.

Fang K, Zhao H, Sun C, Lam CM, Chang S, Zhang K, Panda G, Godinho M, Martins dos Santos VA, Wang J.

BMC Syst Biol. 2011 May 25;5:83. doi: 10.1186/1752-0509-5-83.

PMID:
21609491
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Global changes in gene expression by the opportunistic pathogen Burkholderia cenocepacia in response to internalization by murine macrophages.

Tolman JS, Valvano MA.

BMC Genomics. 2012 Feb 9;13:63. doi: 10.1186/1471-2164-13-63.

PMID:
22321740
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia.

Mil-Homens D, Bernardes N, Fialho AM.

FEMS Microbiol Lett. 2012 Mar;328(1):61-9. doi: 10.1111/j.1574-6968.2011.02476.x. Epub 2012 Jan 6.

PMID:
22150831
[PubMed - indexed for MEDLINE]
13.

Diversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia.

Drevinek P, Baldwin A, Dowson CG, Mahenthiralingam E.

BMC Microbiol. 2008 Mar 7;8:44. doi: 10.1186/1471-2180-8-44.

PMID:
18328098
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A decade of Burkholderia cenocepacia virulence determinant research.

Loutet SA, Valvano MA.

Infect Immun. 2010 Oct;78(10):4088-100. doi: 10.1128/IAI.00212-10. Epub 2010 Jul 19. Review.

PMID:
20643851
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Genetic similarity of Burkholderia cenocepacia from cystic fibrosis patients.

Pretto L, de-Paris F, Mombach Pinheiro Machado AB, Francisco Martins A, Barth AL.

Braz J Infect Dis. 2013 Jan-Feb;17(1):86-9. doi: 10.1016/j.bjid.2012.09.002. Epub 2013 Jan 1.

PMID:
23287542
[PubMed - indexed for MEDLINE]
Free Article
16.

Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum.

Drevinek P, Holden MT, Ge Z, Jones AM, Ketchell I, Gill RT, Mahenthiralingam E.

BMC Infect Dis. 2008 Sep 19;8:121. doi: 10.1186/1471-2334-8-121.

PMID:
18801206
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation.

McDowell A, Mahenthiralingam E, Dunbar KE, Moore JE, Crowe M, Elborn JS.

J Med Microbiol. 2004 Jul;53(Pt 7):663-8.

PMID:
15184539
[PubMed - indexed for MEDLINE]
Free Article
18.

Genome-wide analysis of DNA repeats in Burkholderia cenocepacia J2315 identifies a novel adhesin-like gene unique to epidemic-associated strains of the ET-12 lineage.

Mil-Homens D, Rocha EP, Fialho AM.

Microbiology. 2010 Apr;156(Pt 4):1084-96. doi: 10.1099/mic.0.032623-0. Epub 2009 Dec 17.

PMID:
20019083
[PubMed - indexed for MEDLINE]
Free Article
19.

Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy.

Madeira A, Santos PM, Coutinho CP, Pinto-de-Oliveira A, Sá-Correia I.

Proteomics. 2011 Apr;11(7):1313-28. doi: 10.1002/pmic.201000457. Epub 2011 Feb 17.

PMID:
21337515
[PubMed - indexed for MEDLINE]
20.

The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315).

Silipo A, Molinaro A, Ieranò T, De Soyza A, Sturiale L, Garozzo D, Aldridge C, Corris PA, Khan CM, Lanzetta R, Parrilli M.

Chemistry. 2007;13(12):3501-11.

PMID:
17219455
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk